Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19

Satici C., Cengel F., Gurkan O., Demirkol M. A., Altunok E. S., Esatoglu S. N.

CLINICAL IMAGING, vol.75, pp.119-124, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75
  • Publication Date: 2021
  • Doi Number: 10.1016/j.clinimag.2021.01.028
  • Journal Name: CLINICAL IMAGING
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, Compendex, EMBASE, MEDLINE
  • Page Numbers: pp.119-124
  • Istanbul University Affiliated: Yes


Purpose: There is scarce data on the impact of the presence of mediastinal lymphadenopathy on the prognosis of coronavirus-disease 2019 (COVID-19). We aimed to investigate whether its presence is associated with increased risk for 30-day mortality in a large group of patients with COVID-19.